According to ICICI Securities, Indian Contract Development and Manufacturing Organizations (CDMOs) like Gland Pharma and OneSource (Concord Biotech) could play a key role in manufacturing biosimilar semaglutide for both local and international markets
Complete Diarrhea Timeline: What to Expect Each Week Clinical trial data from 338 Phase 2 participants reveals a remarkably consistent pattern for digestive side effects including diarrhea
Public awareness of GLP-1 medications has also surged in recent years, with about 91% of respondents in 2026 reporting they knew the drugs could treat weight lossup from 80% in 2024
This is a Likert scale, ranging from 1 to 7, with 1 indicating a very distressing quality of life and 7 indicating a high quality of life
Research news Mouse experiments have suggested that glucagon-like peptide-1 receptor agonists may reduce pulmonary fibrosis following a COVID-19 infection in people with type 2 diabetes, although researchers cautioned that the findings remain preliminary Glucagon-like peptide-1 (GLP-1) receptor agonists, already used to treat type 2 diabetes (T2DM) and obesity, may also help to reduce the risk of COVID-19-related lung scarring in people with T2DM, according to research in mouse models
Pre-Injection Steps to Prevent Bruising Prepare your skin 24 hours before your weekly injection